SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-18-012342
Filing Date
2018-12-12
Accepted
2018-12-11 19:59:34
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2182214
2 filename2.htm EX-3 135555
3 filename3.htm EX-4 304831
4 filename4.htm EX-10 256088
5 filename5.htm EX-10 73106
6 filename6.htm EX-10 189326
7 GRAPHIC g630873g00u70.jpg GRAPHIC 110064
8 GRAPHIC g630873g10k16.jpg GRAPHIC 65470
9 GRAPHIC g630873g11l18.jpg GRAPHIC 108500
10 GRAPHIC g630873g14m17.jpg GRAPHIC 77264
11 GRAPHIC g630873g16c46.jpg GRAPHIC 76266
12 GRAPHIC g630873g32y02.jpg GRAPHIC 77018
13 GRAPHIC g630873g36b57.jpg GRAPHIC 82870
14 GRAPHIC g630873g45w09.jpg GRAPHIC 80619
15 GRAPHIC g630873g46d42.jpg GRAPHIC 88924
16 GRAPHIC g630873g49r83.jpg GRAPHIC 76430
17 GRAPHIC g630873g52z15.jpg GRAPHIC 56141
18 GRAPHIC g630873g76b56.jpg GRAPHIC 38400
19 GRAPHIC g630873g94b37.jpg GRAPHIC 57142
  Complete submission text file 0000950123-18-012342.txt   4514508
Mailing Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE CT #250 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-02334 | Film No.: 181229891
SIC: 2836 Biological Products, (No Diagnostic Substances)